Description: Shandong Sito Bio-technology Co., Ltd. researches and develops new steroid hormones, intermediates, and derivatives. Its products include 9a-hydroxyandrostenedione, 17a-hydroxyprogesterone, 17a-hydroxy progesterone derivatives, anecort acetate, dexamethasone epoxy hydrolysate, progesterone intermediate, opener, tetraene, androstenedione, ketal, acid removal, 3-ketal, and betamethasone epoxy hydrolyzate, as well as 1,4-androstenedione. The company was founded in 2002 and is based in Heze, China.
Home Page: www.sitobiotech.com
Renxin industrial park
Heze,
China
Phone:
86 53 0226 3536
Officers
Name | Title |
---|---|
Mr. Qi Mi | Chairman & GM |
Mr. Fuwen Li | Chief Financial Officer |
Ms. Qing Zhi Kong | Deputy Gen. Mang. |
Qingli Zeng | Securities Representative |
Exchange: SHE
Country: CN
Currency: Renminbi (¥)
GIC Sector: | Health Care |
---|---|
GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
GIC Industry: | Pharmaceuticals |
GIC Sub-Industry: | Pharmaceuticals |
Forward PE: | 0 |
---|---|
Trailing PE: | 53.4884 |
Price-to-Book MRQ: | 1.6549 |
Price-to-Sales TTM: | 2.3884 |
IPO Date: | |
Fiscal Year End: | December |
Full Time Employees: | 1140 |